Biotech · Private company · San Diego, CA, US
Stress Therapeutics, Inc.
Track this companyFree. Adds Stress Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)Fiscal year 2026 · $995.4KNIH RePORTER 5U43AA032129-02 · fetched Nov 12, 2026
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s DiseaseFiscal year 2025 · $349.6KNIH RePORTER 1R43AG090243-01A1 · fetched Nov 12, 2026
- Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)Fiscal year 2025 · $999.4KNIH RePORTER 1U43AA032129-01 · fetched Nov 12, 2026
- Novel therapeutic for HPA hyperactivityFiscal year 2025 · $716.7KNIH RePORTER 5R44AA027971-04 · fetched Nov 12, 2026
- Novel therapeutic for HPA hyperactivityFiscal year 2024 · $605.4KNIH RePORTER 5R44AA027971-03 · fetched Nov 12, 2026